New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant-Reference-Cited by-同舟云学术

New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant

Published:2016-05 Issue:5 Volume:89 Page:988-994
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Fabrizi Fabrizio,Martin Paul,Messa Piergiorgio

Publisher

Elsevier BV

Subject

Nephrology

Reference37 articles.

1. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease;Kidney Int,2008

2. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?;Fabrizi;J Viral Hepat,2012

3. Meta-analysis of observational studies: hepatitis C and survival after renal transplant;Fabrizi;J Viral Hepat,2014

4. Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis;Fabrizi;Dig Dis Sci,2015

5. Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies;Petta;Gastroenterology,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of difelikefalin in the treatment of hemodialysis patients with pruritus: A meta-analysis and systematic review;Clinical Nephrology;2024-04-01

2. From the Drugbank Application to the Novel Drugs: A Pharmacogenomic Summary;E3S Web of Conferences;2024

3. Chronic hepatitis C;Yamada's Textbook of Gastroenterology;2022-02-18

4. Adjuvant use of ribavirin with treatment of hepatitis C virus in kidney transplant recipients: A systematic review and meta-analysis of real-world data;Indian Journal of Transplantation;2022

5. Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience;Immunity, Inflammation and Disease;2020-12-02